MedTrace Logo

A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris

NCT02395549 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 364

Last updated 2016-06-16

No results posted yet for this study

Summary

This study is designed to investigate the efficacy, safety and tolerability of MTC896 Gel in subjects with acne. In this study, MTC896 Gel will be applied at 3 concentrations, twice daily (bid) for 12 weeks and compared against a vehicle control.

Conditions

  • Acne Vulgaris

Interventions

DRUG

0.375% (w/w) MTC896 Gel

0.375% (w/w) MTC896 Gel

DRUG

0.75% (w/w) MTC896 Gel

0.75% (w/w) MTC896 Gel

DRUG

1.5% (w/w) MTC896 Gel

1.5% (w/w) MTC896 Gel

DRUG

Vehicle Control Gel

Sponsors & Collaborators

  • Mimetica Pty Limited

    lead INDUSTRY

Principal Investigators

  • Debra Dow · Symbio, LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2016-06-30
Completion
2016-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02395549 on ClinicalTrials.gov